GLP-1 analog treatments potentially alter food preferences and reduce obesity by decreasing appetite and food consumption, with further research needed for long-term weight maintenance using objective measures.
New research sheds light on how GLP-1 obesity drugs may change food cravings
- Post author:
- Post published:March 10, 2024
- Post category:uncategorized